4//SEC Filing
Levy Guy 4
Accession 0001493152-20-009217
CIK 0001327273other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:16 PM ET
Size
31.6 KB
Accession
0001493152-20-009217
Insider Transaction Report
Form 4
Soleus Private Equity GP I, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Soleus Private Equity Fund I, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Soleus Capital, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Soleus PE GP I, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Soleus Capital Master Fund, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Soleus Capital Group, LLC
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Levy Guy
10% Owner
Transactions
- Conversion
Common Stock
2020-05-05+338,330→ 338,330 total(indirect: See footnote) - Conversion
Common Stock
2020-05-05+104,608→ 442,948 total(indirect: See footnote) - Exercise of In-Money
Common Stock
2020-05-05$8.63/sh+31,382$270,827→ 474,330 total(indirect: See footnote) - Sale
Common Stock
2020-05-05$16.00/sh−16,909$270,544→ 457,421 total(indirect: See footnote) - Purchase
Common Stock
2020-05-05$16.00/sh+155,000$2,480,000→ 155,000 total(indirect: See footnote) - Conversion
Series B Convertible Preferred Stock
2020-05-05−11,666,666→ 0 total(indirect: See footnote)→ Common Stock (338,330 underlying) - Conversion
Series C Convertible Preferred Stock
2020-05-05−3,607,224→ 0 total(indirect: See footnote)→ Common Stock (104,608 underlying) - Exercise of In-Money
Common Stock Warrant
2020-05-05−31,382→ 0 total(indirect: See footnote)Exercise: $8.63From: 2020-01-27Exp: 2030-01-27→ Common Stock (31,382 underlying)
Footnotes (4)
- [F1]The securities reported in this row are owned directly by Soleus Private Equity Fund I, L.P. ("Soleus PE"). Soleus Private Equity GP I, LLC ("Soleus GP") is the sole general partner of Soleus PE. Soleus GP holds voting and dispositive power over the shares held by Soleus PE. Soleus PE GP I, LLC is the sole manager of Soleus GP. Mr. Guy Levy is the sole managing member of Soleus PE GP I, LLC. Each of Mr. Guy Levy, Soleus PE GP I, LLC and Soleus GP disclaims beneficial ownership of these securities held by Soleus PE and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F2]The securities reported in this row are held by Soleus Capital Master Fund, L.P. ("Master Fund"). Soleus Capital, LLC is the sole general partner of Master Fund and thus holds voting and dispositive power over the shares held by Master Fund. Soleus Capital Group, LLC is the sole managing member of Soleus Capital, LLC. Mr. Guy Levy is the sole managing member of Soleus Capital Group, LLC. Each Soleus Capital Group, LLC, Soleus Capital, LLC and Mr. Guy Levy disclaims beneficial ownership of these securities held by Master Fund and this report shall not be deemed an admission that they are the beneficial owners of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]On May 5, 2020, Soleus PE exercised a warrant to purchase an aggregate of 31,382 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's initial public offering price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's initial public offering, the Issuer withheld 16,909 of the warrant shares to pay the exercise price and issued the remaining 14,473 shares of common stock to Soleus PE. The Issuer also paid $13.77 to Soleus PE in lieu of a fractional share.
- [F4]Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001812305
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:16 PM ET
- Size
- 31.6 KB